|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 7/56 | |
| C07K 14/81 | |||
| A61K 38/12 |
| (11) | Number of the document | 2183270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08803037.4 |
| Date of filing the European patent application | 2008-08-14 | |
| (97) | Date of publication of the European application | 2010-05-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/060693 |
| Date | 2008-08-14 |
| (87) | Number | WO 2009/024528 |
| Date | 2009-02-26 |
| (30) | Number | Date | Country code |
| 07114505 | 2007-08-17 | EP |
| (72) |
KRASTEL, Philipp, DE
LIECHTY, Brigitta-Maria, CH
SCHMITT, Esther, DE
SCHREINER, Erwin Paul, AT
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 |
| USE OF CYCLIC DEPSIPEPTIDES TO INHIBIT KALLIKREIN 7 |